Quantcast

Columbia News

Tuesday, November 11, 2025

Senator Eric Schmitt discusses Supreme Court case jurisdiction and nitazene legislation

Webp iq5f494dw2qsdnebaojragrz721v

Senator Eric Schmitt | U.S. Senator Eric Schmitt

Senator Eric Schmitt | U.S. Senator Eric Schmitt

Senator Eric Schmitt, U.S. Senator representing Missouri, addressed legal and public health issues in a series of posts on November 5, 2025.

In one post, Schmitt discussed ongoing Supreme Court proceedings involving two consolidated cases: "Third, which court has jurisdiction? The argument today features two consolidated cases—one from the Court of International Trade, the other from a district court. This could have implications for the effects of the SCOTUS ruling, because the posture of the cases below differs." (Nov. 5, 2025). He also provided a link for further reading: "Read more: https://t.co/QOwTPmVKZJ" (Nov. 5, 2025).

On the same day, Schmitt turned his attention to drug policy and enforcement: "We must learn from the fentanyl crisis and get ahead of nitazenes before they spiral out of control. My DETECT Nitazenes Act would empower law enforcement to eliminate these dangerous opioids and protect Missourians and countless other Americans from falling victim to it. https://t.co/llLTBdI3kt" (Nov. 5, 2025).

Nitazenes are a class of synthetic opioids that have been linked to overdose deaths in recent years. Lawmakers and health officials have expressed concern about their potency and potential for abuse as new synthetic drugs continue to emerge in illicit markets.

Schmitt's legislative proposal follows broader efforts by Congress to address opioid-related harm nationwide through regulation and support for law enforcement initiatives.

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate